April 3, 2023 – The contaminated, deadly, blinding eye drops recalled earlier this 12 months were manufactured in India in a factory that was not inspected by the FDA, a latest report says.
Scientists are concerned that the once-rare, treatment-resistant bacteria in the attention drops will be transmitted from individual to individual and will grow to be a recurring problem within the United States. The New York Times reported.
In January, the synthetic tears and ointment products of EzriCare and Delsam Pharma remembered after contact with the bacterium P. aeruginosa. The bacteria have caused no less than 68 infections, including three deaths and no less than eight cases of blindness. The eye drops were imported into the U.S. from India, and most of the cases occurred after the bacteria spread from individual to individual at a long-term care facility in Connecticut, in response to the Justquoting FDA and CDC lead investigator Dr. Maroya Walters, who said the cases leading to death or blindness were because of the synthetic tear product EzriCare.
“It’s very difficult to get rid of it,” University of North Carolina infectious disease specialist David van Duin, MD, PhD, told the Just, Note that the bacteria stick with drains, faucets and other damp places.
The FDA said it had stopped importing the recalled products and had since visited the factory in India where they were manufactured, which is owned by Global Pharma Healthcare. Quote In a March 2 letter to the corporate, the FDA listed nearly a dozen problems, including contaminated equipment and an absence of safety procedures and testing.
